Dermatology Associates

Seattle, Washington 98101

0 studies enrolling now · 22 studies all time

What they study most

Acne Vulgaris, Alopecia Areata, Atopic Dermatitis, Chronic Plaque Psoriasis, Hyperhidrosis, Infected Toenails, Onychomycosis, Plaque Psoriasis, Psoriasis, Psoriasis Vulgaris, Psoriatic Arthritis, Topical Administration

Studies at this site

• A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata — Completed
• Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial) — Completed
• A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis — Completed
• Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis — Completed
• Safety and Tolerability of Repeat Courses of IM Alefacept — Completed
• Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis — Completed
• A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) — Stopped early
• A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis — Completed
• Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis — Completed
• Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis — Completed
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed
• A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) — Completed
• An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris — Completed
• A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis — Completed
• A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis — Completed
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed
• Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients — Completed
• Study to Evaluate the Efficacy and Safety of M518101 in Subjects With Plaque Psoriasis — Completed
• PinPointe FootLaser for the Treatment of Onychomycosis — Completed
• Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice — Completed
• Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy — Completed